Necrotizing enterocolitis in pediatrics

Reading File

Finding Sources

Searching PubMed

"necrotizing enterocolitis"[MeSH Terms] AND infant

Searching Images

necrotizing enterocolitis NEC pediatric radiology pathology

Reading File

Searching PubMed

"necrotizing enterocolitis"[MeSH Terms] AND "infant, premature"[MeSH Terms]

Reading File

Searching PubMed

"necrotizing enterocolitis" treatment prevention

Loading Image

I now have comprehensive content from multiple authoritative sources. Here is the complete, integrated review:

Necrotizing Enterocolitis (NEC) in Pediatrics

Overview

Necrotizing enterocolitis is the most common and lethal gastrointestinal emergency in the neonatal period. It is a severe inflammatory disease of the small and large intestine, occurring in approximately 1 in 1,000 live births overall and in 4–13% of very-low-birth-weight (VLBW) infants (<1,500 g). It affects 1–5% of all NICU admissions. Mortality ranges from 10–30% overall and approaches 50% in surgical cases. — Creasy & Resnik's Maternal-Fetal Medicine, Current Surgical Therapy 14e, Schwartz's Principles of Surgery 11e

Epidemiology & Risk Factors

Prematurity and enteral feeding are the only consistent epidemiologic precursors
Peak incidence at ~32 weeks corrected gestational age; onset has an inverse relationship with gestational age
Higher risk in infants <1,500 g
Other associated risk factors: birth asphyxia, umbilical artery catheterization, patent ductus arteriosus (PDA), cyanotic congenital heart disease, bacterial sepsis, maternal cocaine abuse
NEC occurs in episodic cluster waves abrogated by infection control measures, and almost exclusively in enterally fed infants
Antenatal corticosteroids are protective; antenatal indomethacin tocolysis may be associated with early-onset NEC in some studies (evidence mixed) — Creasy & Resnik's

Pathogenesis

The exact mechanism is multifactorial and incompletely understood, involving a triad of:

Intestinal immaturity — The premature intestinal epithelium over-expresses Toll-like receptor 4 (TLR4), which plays a role in normal gut development. When colonizing bacteria activate TLR4 in the NICU, an exaggerated proinflammatory response is triggered, increasing mucosal permeability via enterocyte apoptosis and tight junction disruption.
Microbial dysbiosis — No single pathogen is causative. Common isolates from blood, peritoneal fluid, and stool in advanced NEC include E. coli, Enterobacter, Klebsiella, and coagulase-negative Staphylococcus. Outbreaks have been linked to Enterobacter sakazakii-contaminated formula. Antibiotic exposure (antenatal and postnatal) increases risk by disrupting the gut microbiome.
Ischemia–inflammation cascade — Mucosal barrier failure allows bacterial translumination, triggering a vicious cycle: inflammation → necrosis → further bacterial entry → systemic sepsis and shock. Circulating proinflammatory cytokines drive multiorgan dysfunction.

Gas-producing enteric bacteria invade the ischemic mucosa, producing the hallmark finding of pneumatosis intestinalis (intramural gas). — Schwartz's Principles of Surgery 11e, Robbins & Cotran Pathologic Basis of Disease

Anatomy of Involvement

NEC most commonly involves the terminal ileum, followed by the cecum and right colon, though any segment can be affected. Gross findings include bowel distension, patchy thinning, pneumatosis, gangrene, and frank perforation. Microscopically: coagulative (bland) infarct, full-thickness necrosis, bacterial colonization, submucosal gas bubbles, and early reparative granulation tissue/fibrosis. — Robbins & Cotran, Robbins & Kumar Basic Pathology

Gross pathology (postmortem exam):

NEC gross pathology — markedly distended small bowel with thin wall (A) and congested ileum with hemorrhagic infarction and submucosal gas bubbles (B)

Fig. 10.8 — (A) Entire small bowel markedly distended with perilously thin wall suggesting impending perforation. (B) Congested ileum with hemorrhagic infarction, transmural necrosis, and submucosal gas bubbles (pneumatosis intestinalis, arrows). — Robbins & Cotran Pathologic Basis of Disease

Clinical Manifestations & Bell Staging

The clinical picture progresses through Bell's staging criteria:

Stage	Category	Systemic Signs	GI Signs	Radiographic Findings	Treatment
IA	Suspected NEC	Temperature instability, apnea, bradycardia, lethargy	Gastric residuals, mild distension, emesis	Normal or intestinal dilation, mild ileus	NPO, bowel rest, rule out sepsis
IB	Suspected NEC	Same	Bright red blood per rectum	Same	Same
IIA	Definite NEC (mildly ill)	Same as above	Absent bowel sounds ± tenderness	Pneumatosis intestinalis	NPO, IV antibiotics 7–10 days
IIB	Definite NEC (moderately ill)	Mild metabolic acidosis, thrombocytopenia	± Abdominal wall cellulitis, palpable mass	Same + portal venous gas, ascites	NPO, antibiotics 14 days
IIIA	Advanced NEC (severely ill, intact bowel)	Hypotension, acidosis, DIC, anuria	Peritonitis, marked distension	Persistent findings	IV fluids, vasopressors, antibiotics, surgical consult
IIIB	Advanced NEC (perforated bowel)	Same + deterioration	Same	Pneumoperitoneum	Surgery

Source: Schwartz's Principles of Surgery 11e, Current Surgical Therapy 14e

Investigations

Laboratory

CBC: leukocytosis or leukopenia, increased bands, thrombocytopenia (concerning finding)
Blood gas: metabolic acidosis
Electrolytes, BUN/Cr (renal dysfunction in advanced disease)
Blood culture (bacteremia common in advanced stages)
CRP, procalcitonin

Radiology

Plain abdominal X-ray (AP + left lateral decubitus) remains first-line:

Pneumatosis intestinalis — pathognomonic; linear or bubbly intramural gas
Bowel dilation / ileus
Portal venous gas — branching lucencies in the liver; indicates severe disease
Pneumoperitoneum — free air (football sign, Rigler's sign); indicates perforation and surgical emergency
Fixed loop — persistent dilated loop on serial films; suggests localized necrosis/perforation

Abdominal ultrasound is more sensitive than plain films for pneumatosis and portal venous gas but its role in surgical decision-making remains under evaluation.

AP abdominal radiograph showing marked bowel distension with dilated loops and pneumatosis intestinalis in a neonate with NEC

Neonatal abdominal X-ray: generalized bowel distension, dilated loops (14.7–17.8 mm), and pneumatosis intestinalis. An enteric feeding tube is in situ.

CT abdomen in NEC — (A) axial view showing portal venous gas throughout the liver (branching hypodense foci); (B) coronal view showing pneumatosis and bowel dilatation

CT findings of advanced NEC: (A) portal venous gas in the liver; (B) pneumatosis intestinalis of the right colon with significant bowel dilatation.

Management

Medical (Bell Stage I–IIA, and selected IIB)

Bowel rest + NPO
Nasogastric tube decompression
Broad-spectrum IV antibiotics — e.g., piperacillin/tazobactam ± metronidazole; typically 7 days from radiographic resolution of pneumatosis (individualized)
Serial clinical assessment, labs, and abdominal X-rays (every 6–8 hours in acute phase)
Correction of metabolic acidosis, coagulopathy, thrombocytopenia
Vasopressor support if hemodynamically unstable

Surgical (20–40% of cases)

Absolute indication: Pneumoperitoneum (intestinal perforation)

Relative indications:

Deteriorating clinical status despite maximal medical management
Abdominal wall erythema/cellulitis
Portal venous gas
Persistent fixed loop on serial X-rays
High clinical suspicion for bowel necrosis

Operative approach:

Transverse superumbilical laparotomy
Full intestinal and colonic exploration
Resection of all frankly necrotic bowel while preserving all viable or questionable bowel ("save every centimeter")
For extensive ischemia without frank necrosis: place a spring-loaded silo and plan second-look operation in 24–48 hours
For well-demarcated disease: create proximal stoma + distal mucous fistula
Ostomy reversal after ≥6 weeks once infant weighs ≥3 kg and tolerates enteral feeds; perform contrast enema ± mucous fistula study before reversal to exclude strictures

Peritoneal drain (bedside): In very-low-birth-weight neonates (<1,000 g) with suspected spontaneous intestinal perforation (SIP), a lower quadrant peritoneal drain (vessel loop or ¼-inch Penrose) is appropriate first-line therapy. — Current Surgical Therapy 14e, Schwartz's Principles of Surgery 11e

NEC vs. Spontaneous Intestinal Perforation (SIP)

Feature	NEC	SIP
Pathology	Widespread patchy ischemia + necrosis	Focal terminal ileal perforation
Shock at presentation	Almost universal	Often absent initially
Associated factors	Prematurity, enteral feeds	Indomethacin, early postnatal steroids
Pneumoperitoneum	Later stage	Presenting feature
Surgical approach	Laparotomy with resection	Peritoneal drain first-line in <1,000 g

Complications

Short bowel syndrome (SBS) — most devastating long-term complication after massive resection; requires intestinal rehabilitation ± transplantation
Post-NEC strictures — fibrous healing can cause obstruction; colonic strictures most common; investigate with contrast enema before ostomy reversal
Recurrent NEC
Cholestatic liver disease — secondary to prolonged TPN
Neurodevelopmental impairment — NEC is an independent risk factor for adverse neurodevelopmental outcomes in VLBW infants
Growth failure

Prevention

Strategy	Evidence
Human breast milk (preferably mother's own milk)	Meta-analysis: ~4-fold reduction in NEC (RR 0.25) vs. formula
Standardized feeding protocols	Shown to reduce incidence in VLBW infants
Probiotics	Multiple RCTs and meta-analyses support risk reduction; implementation varies by institution
Antenatal corticosteroids	Protective (accelerates gut maturation)
Infection control	Aborts epidemic clusters
Avoidance of unnecessary antibiotics	Reduces dysbiosis
Donor human milk (if mother's own milk unavailable)	Preferred over formula for high-risk premature infants

Mothers of infants <32 weeks' gestation should be actively encouraged and supported in providing breast milk; early antenatal counseling increases lactation initiation without increasing maternal stress. — Creasy & Resnik's Maternal-Fetal Medicine

Prognosis

Overall mortality: 10–50% (varies by center and disease severity)
Surgical NEC mortality: approaches 50%
Survivors are at significant risk for SBS, strictures, and neurodevelopmental delay
Quality improvement initiatives in recent years have successfully reduced NEC incidence even in the highest-risk populations

Recent literature (2024–2025): Reviews by Roberts et al. (Paediatr Drugs, 2024, PMID 38564081) and Zhang et al. (Gut Microbes, 2025, PMID 39826099) highlight evolving understanding of the microbiome's role in NEC pathogenesis and emerging therapeutic targets. The microbiome perspective — specifically Bifidobacterium-dominant colonization via human milk — is increasingly recognized as central to both prevention and future treatment strategies.

Sources: Schwartz's Principles of Surgery 11e · Current Surgical Therapy 14e · Creasy & Resnik's Maternal-Fetal Medicine · Robbins & Cotran Pathologic Basis of Disease · Robbins & Kumar Basic Pathology

Why gain weight

Asking for Preferences

Reading File

Searching the Web

causes of weight gain physiology mechanisms

Finding Sources

Reading File

Here is a comprehensive answer covering why humans gain weight — from basic physiology to medical causes:

Why Do Humans Gain Weight?

Weight gain occurs when energy intake chronically exceeds energy expenditure, causing the body to store the surplus primarily as fat. But this simple equation sits on top of a highly complex biological system.

1. The Energy Balance Equation

Body weight = Energy In − Energy Out

Energy In: Calories from food and drink
Energy Out: Made up of four components:
- Resting metabolic rate (RMR) — ~60–70% of total expenditure; energy used at rest for organ function, circulation, breathing
- Thermic effect of food (TEF) — ~10%; energy used to digest and metabolize food
- Voluntary exercise — variable
- NEAT (Non-Exercise Activity Thermogenesis) — energy from spontaneous movement like fidgeting, posture, daily activities; highly variable between individuals and a major determinant of weight gain susceptibility

When energy intake persistently exceeds all four of these, the surplus is converted to triglycerides and stored in adipose tissue.

2. Hormonal & Neurological Regulation

The brain — specifically the hypothalamus — acts as the master controller of appetite and body weight:

Leptin — secreted by adipose tissue in proportion to fat mass; acts on hypothalamic receptors to suppress appetite and increase energy expenditure. In obesity, leptin resistance develops (similar to insulin resistance), so high leptin levels fail to suppress hunger — a key driver of progressive weight gain. — Fitzpatrick's Dermatology
Ghrelin — the "hunger hormone," secreted by the stomach; rises before meals and promotes food intake
GLP-1, PYY, CCK — gut hormones released after eating that signal satiety to the brain
Insulin — promotes fat storage; chronically elevated insulin (as in insulin resistance) favors fat accumulation, especially visceral fat
Melanocortin pathway (POMC/MC4R) — mutations in MC4R account for up to 6% of severe early-onset obesity; this pathway is downstream of leptin signaling
AgRP — a hypothalamic antagonist that drives feeding behavior when activated

When satiety signals are impaired or hunger signals are chronically elevated, the set point for body weight shifts upward. — Fitzpatrick's Dermatology, Fuster & Hurst's The Heart 15e

3. Common Causes of Weight Gain

A. Behavioral / Lifestyle

Excess caloric intake (especially ultra-processed, energy-dense foods)
Physical inactivity / sedentary lifestyle
Poor sleep (raises ghrelin, lowers leptin, increases hunger)
Chronic stress (elevates cortisol → increases appetite for energy-dense foods)
Emotional/stress eating

B. Physiological / Life Stages

Aging — resting metabolic rate declines ~1–2% per decade after age 30; muscle mass decreases (sarcopenia), reducing calorie burn
Pregnancy — intentional weight gain for fetal development
Menopause — estrogen decline shifts fat distribution toward visceral/abdominal fat
Puberty — normal developmental weight and fat gain

C. Endocrine / Medical Causes

Condition	Mechanism
Hypothyroidism	Low thyroid hormone → reduced metabolic rate, fluid retention
Cushing's syndrome	Excess cortisol → central adiposity, muscle wasting
PCOS	Insulin resistance → hyperinsulinemia → fat storage
Hypothalamic disorders	Damage to satiety centers (tumors, trauma) → uncontrolled hyperphagia
Type 2 diabetes / insulin resistance	Hyperinsulinemia promotes fat storage; impaired fat mobilization
Growth hormone deficiency	Reduced lipolysis, increased fat mass
Depression	Reduced activity, appetite dysregulation

D. Medications (Iatrogenic Weight Gain)

Corticosteroids — increase appetite, promote central fat redistribution
Antipsychotics (olanzapine, clozapine) — block dopamine/serotonin receptors, increase appetite
Antidepressants (TCAs, mirtazapine, paroxetine)
Insulin and sulfonylureas — fat-anabolic effects
Beta-blockers — reduce metabolic rate, cause fatigue limiting exercise
Antihistamines, anticonvulsants (valproate, gabapentin)
Hormonal contraceptives — some formulations

E. Genetic Factors

Obesity is largely polygenic — familial studies show strong heritability. Rare monogenic causes include leptin deficiency, leptin receptor mutations, POMC deficiency, and MC4R mutations. Most common obesity, however, involves the interplay of many genes with environmental and behavioral factors.

4. The Vicious Cycle of Weight Gain

Once weight gain begins, comorbid factors can perpetuate further weight gain:

Excess weight → inflammation + insulin resistance → depression + joint pain + sleep apnea → reduced activity + emotional eating + fatigue → more weight gain

Visceral fat (intra-abdominal) is particularly harmful: it secretes inflammatory adipokines, reduces adiponectin (a protective hormone), worsens insulin resistance, and accelerates cardiovascular and metabolic disease. — Fuster & Hurst's The Heart 15e

Summary

Weight gain is ultimately driven by a positive energy balance, but the reasons that energy balance tilts positive are multifactorial — behavioral, hormonal, genetic, pharmaceutical, and medical. No single cause applies to everyone, which is why effective weight management requires identifying the individual's specific drivers.

Why weight gain here ti this patient before surgery

Reading File

Finding Sources

Searching the Web

NEC necrotizing enterocolitis weight gain before ostomy reversal surgery requirement

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

This is a shared conversation. Sign in to Orris to start your own chat.